Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience.
Gimenez-Arnau A, Bartra J, Ferrer M, Jauregui I, Borbujo J, Figueras I, Muñoz-Bellido FJ, Pedraz J, Serra-Baldrich E, Tejedor-Alonso MA, Velasco M, Terradas P, Labrador M. Gimenez-Arnau A, et al. J Investig Allergol Clin Immunol. 2022 Jun 20;32(3):191-199. doi: 10.18176/jiaci.0661. Epub 2020 Dec 22. J Investig Allergol Clin Immunol. 2022. PMID: 33349612 Free article.
Association Between Severity of Anaphylaxis and Co-occurrence of Respiratory Diseases: A Systematic Review and Meta-analysis of Observational Studies.
Tejedor-Alonso MA, Farias-Aquino E, Pérez-Fernández E, Moro-Moro M, Rosado-Ingelmo A, Alberti Masgrau N, Pérez-Codesido S, Privitera-Torres M. Tejedor-Alonso MA, et al. J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):132-144. doi: 10.18176/jiaci.0462. Epub 2019 Oct 22. J Investig Allergol Clin Immunol. 2021. PMID: 31638577 Free article.
Incidence of Fatal Anaphylaxis: A Systematic Review of Observational Studies.
Perez-Codesido S, Rosado-Ingelmo A, Privitera-Torres M, Pérez Fernández E, Nieto-Nieto A, Gonzalez-Moreno A, Grifol-Clar E, Alberti-Masgrau N, Tejedor-Alonso MA. Perez-Codesido S, et al. J Investig Allergol Clin Immunol. 2022 Jul 22;32(4):245-260. doi: 10.18176/jiaci.0693. Epub 2020 Apr 15. J Investig Allergol Clin Immunol. 2022. PMID: 33856349 Free article.
Anaphylactic Reactions With 3 Nonrelated Drugs (Gadoteridol, Paclitaxel, Bevacizumab) in a Patient With Severe Comorbidities.
González-Bravo L, Laiseca García J, Alonso-Díaz-de-Durana MD, Nieto Nieto A, Álvarez-Twose I, Tejedor Alonso MA, Alfaya Arias T. González-Bravo L, et al. Among authors: tejedor alonso ma. J Investig Allergol Clin Immunol. 2022 Apr 19;32(2):161-163. doi: 10.18176/jiaci.0729. Epub 2021 Jul 2. J Investig Allergol Clin Immunol. 2022. PMID: 34213420 Free article. No abstract available.
First-Line Versus Second-Line Use of Reslizumab in Severe Uncontrolled Asthma.
Pérez de Llano LA, Cosío BG, Lobato Astiárraga I, Soto Campos G, Tejedor Alonso MA, Marina Malanda N, Padilla Galo A, Urrutia Landa I, Michel de la Rosa FJ, García-Moguel I; Reslizumab Real-Life Spanish group. Pérez de Llano LA, et al. Among authors: tejedor alonso ma. J Investig Allergol Clin Immunol. 2023 Jun 15;33(3):220-222. doi: 10.18176/jiaci.0839. Epub 2022 Jul 7. J Investig Allergol Clin Immunol. 2023. PMID: 35797112 Free article. No abstract available.
36 results